esperion | The MotorSportsNews.Net(work)

RFK Racing Teams Up with Esperion for the Wellness Walk at Pocono

by MikeJune 17, 2025

CONCORD, N.C. (June 17, 2025) – In its continued effort to promote heart health, RFK Racing partner Esperion will host a one-mile Wellness Walk at Pocono Raceway on Saturday, June 21, following the conclusion of the NASCAR Xfinity Series race. Chris Buescher will lead the walk, which will take place on the front stretch and pit road.

Fans and attendees are invited to participate in the walk, encouraging the NASCAR community to take steps toward better cardiovascular health. The event is part of RFK Racing and Esperion’s shared commitment to raising awareness around heart wellness and supporting healthier lifestyles through simple, everyday actions.

(more…)

RFK Announces Annual Fan Day on Friday, May 24

by MikeMay 3, 2024

CONCORD, N.C. (May 2, 2024) – RFK Racing has announced that its annual Fan Day will be held on May 24 ahead of the famed Coca-Cola 600 on Memorial Day Weekend. Highlights for the fan event include driver autograph sessions, shop tours, RFK partner displays and SiriusXM hits throughout the team’s footprint on its Concord, North Carolina campus. (more…)

RFK, Esperion Therapeutics Announce 2024 Promotional Schedule

by MikeFebruary 2, 2024

CONCORD, N.C. (Feb. 1, 2024) – RFK Racing and Esperion Therapeutics have announced the promotional schedule for the 2024 season, highlighted by a four-race slate, and numerous accompanying campaigns and initiatives, all driving awareness of its two brands – NEXLIZET (bempedoic acid and ezetimibe) and NEXLETOL (bempedoic acid) used for adults on a statin to reduce LDL-cholesterol. (more…)

RFK Announces Team-Wide Partnership with Esperion Therapeutics; Includes Primary Partnership for Brad Keselowski at the ’23 Daytona 500

by MikeJanuary 11, 2023

CONCORD, N.C. (Jan. 11, 2023) – RFK Racing has announced that Esperion Therapeutics, a Michigan-based pharmaceutical company, has partnered with the team for a multi-year agreement pursuant to which Esperion will promote two cholesterol lowering treatments – NEXLIZET (bempedoic acid and ezetimibe) and NEXLETOL (bempedoic acid).

(more…)